As of 2025-09-16, the Fair Value of Integra Lifesciences Holdings Corp (IART) is -34.80 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 15.07 USD, the upside of Integra Lifesciences Holdings Corp is -330.93%.
With the market price of 15.07 USD and our fair value calculation, Integra Lifesciences Holdings Corp (IART) is not a good investment. Investing in IART stocks now will result in a potential loss of 330.93%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 133.90 | 169.10 | 180.60 | 67.74 | -6.94 | 108.88 |
| YoY growth | 166.73% | 26.29% | 6.80% | -62.49% | -110.25% | 5.42% |
| Market Cap (mil) | 1,174.10 |
| P/E | |
| Forward P/E | 96.61x |
| EPS | -6.43 |
| Avg earnings growth rate | 5.42% |
| TTM earnings | -500.63 |